Comparison of Symptoms and Lung Function in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Monobronchodilators and Dual Bronchodilators

Elfia Damaiyanti Br Lingga; Pandiaman Pandia; Andika Pradana

doi:10.47353/jsocmed.v3i11.169

Comparison of Symptoms and Lung Function in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Monobronchodilators and Dual Bronchodilators

Elfia Damaiyanti Br Lingga
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan indonesia
Pandiaman Pandia
Division of Pulmonary Intervention, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Andika Pradana
Division of Pulmonary Intervention, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

Abstract

Introduction: In COPD treatment with a monobronchodilator or dualbronchodilator, can be assessed for the prognosis of therapy outcomes provided to monitor the impact of intervention and recovery of daily activities, prevent acute exacerbations, and improve the productivity of patient’s COPD. To determine the comparison between symptoms and lung function in patients with COPD disease receiving monobronchodilator and dual bronchodilator.

Method: This study is a retrospective cohort study. The research sample consists of COPD patients undergoing treatment with monobronchodilator or dualbronchodilator for a minimum of 3 months or 3 treatment visits. Symptoms are measured using mMRC and lung function is measured using spirometry (FEV1).

Results: The majority of patients are male (87.1%) and over 60 years old (62.4%), with the majority being smokers (84.7%), and the most common therapy being monobronchodilator (62.4%) and dual bronchodilator (37,6%). There are differences in symptoms and lung function in patients receiving monobronchodilator and dual bronchodilator.

Conclusion: The dual bronchodilator is more effective in reducing mMRC values, improving by 96.3%, and increasing spirometry values. The average FEV1 value in spirometry for patients using the dualbronchodilator increased by 13,907%, while for the monobronchodilator, it decreased by 5.589%.

Similar Articles

Sabrina Dwi Putri, Alfansuri Kadri, Haflin Soraya Hutagalung, Factors Affecting Malnutrition in Parkinson's Disease Patients Using Mini Nutritional Assessment at H. Adam Malik Hospital and Network Hospitals , Journal of Society Medicine: Vol. 3 No. 11 (2024): November
Rina Sari Mardia, Bintang YM Sinaga, Parluhutan Siagian, Ashar Taufik, Characteristics of Loss to Follow-Up Patient in Drug-Sensitive Pulmonary TB in Medan , Journal of Society Medicine: Vol. 3 No. 10 (2024): Oktober
Muhammad Ferhat E.S, Zainal Safri, Yuke Sarastri, Interleukin-6 Reduction as a Predictor of Functional Capacity Improvement after Phase II Cardiac Rehabilitation Programme in Coronary Artery Bypass Surgery Patients , Journal of Society Medicine: Vol. 3 No. 2 (2024): February
Army Zaka Anwary, Indriasari, Role of CRRT (Continuous Renal Replacement Therapy) as Management of Cardiac Arrest Patient with Postpartum Acute Lung Edema and Cardiomyopathy in the ICU , Journal of Society Medicine: Vol. 2 No. 6 (2023): June
Artha Wahyu Wardana, Muchammad Erias Erlangga, Management of Guillain-Barré Syndrome with Respiratory Distress in a Pregnant Woman: A Case Report , Journal of Society Medicine: Vol. 3 No. 1 (2024): January
Sofi Oktaviera Sinaga, Kiking Ritarwan, Kiki Mohammad Iqbal, Relationship between Cluster of Differentiation 4 Levels and Neuroopthalmic Manifestations in HIV Patients in Haji Adam Malik General Hospital Medan , Journal of Society Medicine: Vol. 2 No. 11 (2023): November
Cindy Giovanni, Nurita Dian Kestriani Saragi Sitio, Role of Intravenous Immunoglobulin (IVIG) in Patients with Guillain Barre Syndrome with Severe Community Pneumonia in The Intensive Care Unit (ICU) , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
Faisal Adam, Cut Aryfa Andra, Hilfan Ade Putra Lubis, The Relationship between Heart Rate Recovery and Rate Pressure Product on Coronary Lesion Severity Using Syntax Score in Stable Angina Pectoris Patients at Haji Adam Malik Hospital Medan , Journal of Society Medicine: Vol. 3 No. 7 (2024): July
Natassya Sandra Tillasman, Putu Pradnyasanti Laksmi, Ratna Rayeni Natasha Roosseno, Agus Roy Rusly Hariantana Hamid, Literature Review for Iliaca, Scapula, and Fibula Free Flap as A Modality in Mandibular Ameloblastoma Reconstruction , Journal of Society Medicine: Vol. 3 No. 6 (2024): June
Dadang Mulyawan, Osmond M. Pison, Management of Peripartum Cardiomyopathy in Severe Preeclampsia Patients in ICU , Journal of Society Medicine: Vol. 3 No. 2 (2024): February

<< < 1 2 3 4 5 > >>

You may also start an advanced similarity search for this article.

PDF

Published at

30. November 2024
https://doi.org/10.47353/jsocmed.v3i11.169
Issue:

Vol. 3 No. 11 (2024): November
Section:

Articles
Keywords:

COPD Monobronchodilator Dualbronchodilator Symptoms COPD Lung Function
References:

Tamondong Lachica DR, Skolnik N, Hurst JR, Marchetti N, Rabe APJ, Oca MM, et al. Implications for Clinical Practice. Int J COPD. 2023; 18: 54-745.

Batte C, Semulimi AW, Mutebi RK, Twinamasiko N, Muyama SR, Mukisa J, et al. Cross-sectional validation of the COPD Assessment Test (CAT) among chronic obstructive pulmonary disease patients in rural Uganda. PLOS Glob Public Heal. 2023; 3: 1-10.

Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) a systematic review and modelling analysis. Lancet Respir Med. 2022; 10: 58-447.

Cheng SL, Lin CH. Copd guidelines in the asia-pacific regions: Similarities and differences. Diagnostics. 2021; 11: 1-11.

Kang J, Lee JS, Lee SW, Lee JB, Oh YM. Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials. Respir Res. 2021; 22: 1-11.

Singh D, Donohue JF, Boucot IH, Barnes NC, Compton C, Martinez FJ, et al. Future concepts in bronchodilation for COPD: dual-versus monotherapy. European Respiratory Review. 2021 30: 1-160.

Fazekas PV, Fekete M, Balazs P, Árva D, Pénzes M, Tarantini S, et al. Health-related quality of life of COPD patients aged over 40 years. 2021; 108: 73-261.

Marfiani E, Ichwani J, Widajanti N, Maranatha D, Amin M. Relationship between level of serum adiponectin and frailty in elderly patients with chronic obstructive pulmonary disease. Indones J Trop Infect Dis. 2020; 8: 7-101.

Gogou E, Hatzoglou C, Zarogiannis SG, Siachpazidou D, Gerogianni I, Kotsiou OS, et al. Are younger COPD patients adequately vaccinated for influenza and pneumococcus. 2022; 203: 106-988.

Akbar Y, Mursal M, Amni R. Anxiety Levels of COPD Sufferers Are Stable in Indonesia. J Islam Nurs. 2022; 7: 28-33.

Rodriguez MES, Silveyra P. Air Pollution Exposure as a Relevant Risk Factor for COPD Exacerbations in Male and Female Patients. 2021; 1: 1-18.

Carlson SA. Geographic differences in sex-specific chronic obstructive pulmonary disease mortality rate trends among adults aged≥ 25 years-United States. MMWR Morb Mortal Wkly Rep. 2022; 71: 1-145.

Buttery SC, Zysman M, Vikjord SAA, Hopkinson NS, Jenkins C, Vanfleteren LEGW. Contemporary perspectives in COPD: patient burden, the role of gender and trajectories of multimorbidity. Respirology. 2021; 26: 41-419.

Lindberg A, Szakacs E, Stridsman C, Sawalha S, Nilsson U, Hedman L, et al. Among both men and women with COPD ever-smokers have higher disease burden and worse prognosis than never-smokers. Eur Respiratory Soc. 2022; 1: 1-10.

Saklani S, Bisht S, Joshi Y. Assessment of Demographic, Etiologic and Co-morbidity Status Among COPD Patients. World J Pharm Sci. 2022; 1: 5-10.

Cherepii N V. Identification and Assessment of the Chronic Obstructive Pulmonary Disease Risk Factors in First Diagnosed Patients. 2017; 21: 6-121.

Ramli R, Ismansyah I, Andrianur F. The Effect of Clapping Technique and Deep Breathing Relaxation on Oxygen Saturation in COPD Patients at the Emergency Room of Dr. H. Soemarno Sosroatmodjo Tanjung Selor. Aspiration Heal J. 2023; 1: 20-212.

Isnainy UCAS, Tias SA. The effect of forward leaning position and pursed lips breathing therapy on the degree of shortness of breath in patients with Chronic Obstructive Pulmonary Disease (COPD). Holistik J Kesehat. 2019; 13: 95-389.

Lestari NKY, Saraswati NLGI. The Effect of Yoga Pranayama on the Quality of Life of COPD Patients at Sanjiwani Hospital, Gianyar. Malahayati Nurs J. 2022; 4: 46-3335.

LARISA FZ, SUHANA S. Study on smoking behavior intention of chronic obstructive pulmonary disease (COPD) patients at X Hospital Bandung. Pros Psikol. 2015; 11: 597-604.

Ekaputri M, Ariani Y. Smoking Cessation Efforts Towards Improving Self-Care in Patients with Chronic Obstructive Pulmonary Disease (PPOK). In: Talenta Conference Series: Tropical Medicine (TM). 2018; 1: 90-387.

Dobler CC. In tobacco smokers with respiratory symptoms, a dual bronchodilator did not reduce symptoms at 12 wk. Ann Intern Med. 2023; 1: 1-176.

Han MK, Ye W, Wang D, White E, Arjomandi M, Barjaktarevic I, et al. Bronchodilators in Symptomatic Tobacco-exposed Persons with Preserved Spirometry for the RETHINC Study Group. Eur Respiratory Soc. 2022; 1: 1-17.

Singh D, Donohue JF, Boucot IH, Barnes NC, Compton C, Martinez FJ. Future concepts in bronchodilation for COPD: dual-versus monotherapy. Eur Respir Rev. 2021; 30: 1-160.
Share:

Z

Lingga, E. D. B., Pandia, P., & Pradana, A. (2024). Comparison of Symptoms and Lung Function in Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Monobronchodilators and Dual Bronchodilators. Journal of Society Medicine, 3(11), 346–352. https://doi.org/10.47353/jsocmed.v3i11.169